Cognex (NASDAQ:CGNX) Announces Quarterly Earnings Results

Cognex (NASDAQ:CGNXGet Free Report) posted its quarterly earnings results on Wednesday. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.03, FiscalAI reports. The company had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.82%. The business’s quarterly revenue was up 16.9% on a year-over-year basis. During the same period last year, the business posted $0.25 EPS. Cognex updated its FY 2026 guidance to 1.640-1.680 EPS and its Q3 2026 guidance to 0.500-0.540 EPS.

Cognex Price Performance

Shares of CGNX stock opened at $67.38 on Friday. The stock’s fifty day simple moving average is $64.99 and its 200 day simple moving average is $57.09. Cognex has a one year low of $34.60 and a one year high of $72.88. The firm has a market cap of $11.21 billion, a price-to-earnings ratio of 65.42 and a beta of 1.49.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be paid a $0.085 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $0.34 annualized dividend and a yield of 0.5%. Cognex’s payout ratio is currently 40.48%.

Insider Activity at Cognex

In related news, VP Laura Ann Macdonald sold 98,122 shares of Cognex stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $66.80, for a total transaction of $6,554,549.60. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at $351,234.40. This trade represents a 94.91% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Darren Marc Long sold 20,252 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the sale, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. This represents a 83.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 224,847 shares of company stock valued at $14,975,098 in the last ninety days. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Cognex

Large investors have recently made changes to their positions in the company. Kestra Advisory Services LLC acquired a new stake in shares of Cognex in the 4th quarter valued at approximately $99,000. Brooklyn Investment Group acquired a new position in shares of Cognex in the fourth quarter valued at approximately $201,000. Danske Bank A S bought a new stake in shares of Cognex during the third quarter worth $91,000. iSAM Funds UK Ltd bought a new stake in Cognex in the 3rd quarter valued at $135,000. Finally, Van ECK Associates Corp increased its holdings in Cognex by 17.2% during the 3rd quarter. Van ECK Associates Corp now owns 4,446 shares of the scientific and technical instruments company’s stock worth $201,000 after purchasing an additional 653 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

More Cognex News

Here are the key news stories impacting Cognex this week:

  • Positive Sentiment: Second-quarter adjusted EPS was $0.45, above the $0.42 analyst consensus and up from $0.25 a year earlier. Revenue reached a record $291.3 million, rising 16.9% year over year, while net income increased sharply. Margin improvement, favorable product mix, and cost controls supported the earnings beat. Cognex Q2 Earnings Beat on Margin Gains Despite Revenue Miss
  • Positive Sentiment: Cognex raised its outlook. Third-quarter revenue guidance of $300 million to $320 million and EPS guidance of $0.50 to $0.54 are well above consensus estimates of $279.2 million and $0.37, respectively. Full-year 2026 EPS guidance was raised to $1.64-$1.68, versus the prior analyst estimate of $1.48, with revenue projected at $1.13-$1.15 billion. Cognex Corporation 2026 Q2 Results Earnings Call Presentation
  • Positive Sentiment: The company declared a quarterly dividend of $0.085 per share, payable September 3 to shareholders of record August 20. The payout provides a modest shareholder return, although the reported yield is approximately 0.5%. Cognex Delivers Record Q2 Results and Raises Dividend
  • Neutral Sentiment: Management attributed growth to broad-based strength across most major end markets, which supports the recovery outlook for Cognex’s industrial machine-vision business. However, investors will look for this momentum to translate into sustained revenue growth.
  • Negative Sentiment: Quarterly revenue narrowly missed the $292.1 million consensus estimate. For a stock trading at a relatively high earnings multiple, even a small top-line miss may outweigh the EPS beat and strong forward guidance. Cognex Misses Q2 CY2026 Revenue Estimates
  • Negative Sentiment: Reported insider activity showed company insiders selling shares without recorded purchases during the past six months. While such sales may reflect routine diversification, they can add to investor caution following the earnings release.

Wall Street Analysts Forecast Growth

CGNX has been the topic of a number of recent research reports. Zacks Research raised Cognex from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 16th. The Goldman Sachs Group reiterated a “buy” rating and issued a $80.00 price objective (up from $70.00) on shares of Cognex in a research report on Monday, May 11th. Needham & Company LLC lifted their price objective on Cognex from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Truist Financial boosted their price objective on Cognex from $61.00 to $71.00 and gave the company a “hold” rating in a research report on Thursday, July 2nd. Finally, DA Davidson set a $62.00 target price on Cognex and gave the stock a “neutral” rating in a research report on Thursday, May 14th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $72.31.

Check Out Our Latest Stock Analysis on CGNX

Cognex Company Profile

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

See Also

Earnings History for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.